RecruitingNot ApplicableNCT07490522

The Remote Monitoring of Gout Feasibility Study in Primary Care

The Self-management App 'MinUrinsyregikt' for Patients With Gout. The ReMonit Gout Feasibility Study in Primary Care


Sponsor

Diakonhjemmet Hospital

Enrollment

50 participants

Start Date

Apr 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this feasibility study is to determine the feasibility of a patient self-management app (MinUrinsyregikt) for patients with gout. The primary objectives of the study are: 1. To determine the feasibility of a patient self-management app for patients with gout receiving GP follow-up. 2. To determine the feasibility of conducting a future randomised controlled trial to test the effectiveness of the app for patients with gout in primary care. Participants will be asked to test the self-management app for 3 months. Data will be collected from the participants and their GPs.


Eligibility

Min Age: 18 Years

Inclusion Criteria11

  • Patients are eligible to be included in the study only if all the following criteria apply:
  • Adults ≥18 years of age at screening
  • Patients with a clinical diagnosis of gout
  • Serum urate level >360 µmol/L at inclusion
  • Indication for urate lowering therapy assessed by medical doctor
  • Having a smartphone/tablet
  • Patients are excluded from the study if any of the following criteria apply:
  • Pregnant or breastfeeding
  • Contraindication for urate lowering therapy
  • Does not understand Norwegian language
  • Major co-morbidities (e.g., malignancies, severe chronic kidney disease, severe mental disorders)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPatient self-management app 'MinUrinsyregikt'

The purpose of the 'MinUrinsyregikt' -app is to support self-management for patients with gout receiving urate lowering therapy. The content of the app reflects current treatment recommendations for gout. The app includes information videos and texts about gout and gout treatment, registration tools for gout flares, serum urate levels, and medication adherence. The app enables reminder alerts for medications and for blood sampling. After the monthly blood test of serum urate levels, the patients will register this value in the app and respond to two questions to validate the serum urate blood test value. The app will then provide a date for the next blood test and advice the patient to contact their GP if the serum urate level is over the treatment target.


Locations(1)

Diakonhjemmet Hospital

Oslo, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07490522


Related Trials